跳至主要内容
临床试验/NCT00993551
NCT00993551已完成不适用

Timing of Primary Surgery for Cleft Palate

Kevin Munro27 个研究点 分布在 5 个国家目标入组 558 人开始时间: 2010年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
558
试验地点
27
主要终点
The primary outcome measure for the TOPS trial is insufficient velopharyngeal function.

研究概览

简要总结

This trial is a randomised controlled trial with a parallel design taking place in centres across the UK, Scandinavia and Brazil.

650 infants with a diagnosis of isolated cleft palate who are considered medically fit for operation at 6 months, and who meet the inclusion criteria, will be included in the trial and randomised to receive either:

  • Surgery at age 6 months, OR
  • Surgery at age 12 months.

The main objective is to determine whether surgery for cleft palate, using a Sommerlad technique, at age 6 months, when compared to surgery using the same technique at age 12 months, improves velopharyngeal function at age 5 years. All infants will be followed up at age 12 months, 3 years and five years for the assessment of the primary outcomes( at age 5 years) and secondary outcomes.

详细描述

Infants will be followed up at age 12 months, 3 years and five years. At each visit the following will be assessed:

Age 12 months

  • Speech development (canonical babbling)
  • Audiological assessments
  • Growth

Age 3 years

  • Speech development
  • Audiological assessments

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Infants with isolated cleft palate
  • Medically fit for operation at 6 months, corrected for gestational age
  • Written informed proxy consent
  • One parent/carer a native language speaker in the country of residence

排除标准

  • Consent not obtained
  • b. Infants with syndromic cleft palate (except Van der Woude syndrome, which can be included if hearing is not affected) or severe developmental delay
  • Congenital sensorineural hearing loss or middle ear anomalies;
  • Variation in the anatomical presentation is such that the surgeon who will perform the procedure considers that one stage closure with the Sommerlad technique would be inappropriate;
  • Submucous cleft palate (defined by the classical triad of signs, bifid, uvula, bony defect of the hard palate, muscular diastasis, as described by Jensen et al (1988).
  • Where the language spoken at home is not the majority language in the country of residence.

研究组 & 干预措施

6 month surgery

Experimental

Infants will receive primary surgery at age 6 months using Sommerlad technique.

干预措施: primary surgery for cleft palate (Procedure)

12 month surgery

Experimental

Infants will receive primary surgery at age 12 months using Sommerlad technique

干预措施: primary surgery for cleft palate (Procedure)

结局指标

主要结局

The primary outcome measure for the TOPS trial is insufficient velopharyngeal function.

时间窗: 5 years

Unit of measure: Sufficient (VPC sum \<=3) or insufficient (VPC sum\>=4). VPC sum measured on scale from 1 to 6.

Insufficient Velopharyngeal Function

时间窗: 5 years of age

Measured by the Velopharyngeal Composite Score (VPC sum), which is a sum of scores, based on three components: hypernasality, non-oral errors, and VPI symptoms. Each component is scored between 0 and 2. The sum of the three scores gives the VPC sum (0-6). Scores ≥ 4 on this scale are considered insufficient (higher scores indicate a worse outcome). This outcome is measured as a dichotomous variable (insufficient or not insufficient) with a cut-off threshold of ≥ 4 to indicate insufficient. We report this as a percentage of participants that are assessed as having insufficient velopharyngeal function.

次要结局

  • Hearing level assessment(3 and 5 years)
  • Hearing: hearing level assessment(12 months)
  • Velopharyngeal function;1.Velopharyngeal composite score summary (VPC sum) 2.Insufficient velopharyngeal function (VPC rate)(3 and 5 years)
  • Velopharyngeal function: Velopharyngeal insufficiency symptoms(3 years)
  • Articulation: 1.Percent Correct Placement (PCP) 3. Percent Correct Manner (PCM) 4. Non-oral consonant errors 5. Oral consonant errors(3 and 5 years)
  • Postoperative/long term complications(at 3 and 5 year follow up)
  • Canonical babbling; 1.Canonical babbling present 2.Canonical babbling ratio(12 months)
  • Canonical babbling; 3.Consonant inventory(12 months)
  • Articulation: 1. Percent consonant correct (PCC)(3 and 5 years)
  • Hearing level assessment for: 1. Abnormal Puretone audiometry in one and or both ears.(3 and 5 years)
  • Middle ear function(12 months, 3 and 5 years)
  • Dentofacial development: Soft tissue ANB (the angle between soft tissue nasion,(5 years)
  • Growth assessment for nude weight(12 months)
  • Dentofacial development; Maxillary arch constriction score(5 years)
  • Growth Assessment for crown to heel length and occipitofrontal circumference(12 months)
  • Dentofacial Development: Soft Tissue ANB(5 years of age)
  • Dentofacial Development: Maxillary Arch Constriction Score(5 years of age)
  • Growth: Nude Weight(1 year of age)
  • Growth: Crown to Heel Length(1 year of age)
  • Growth: Occiptofrontal Circumference(1 year of age)
  • Velopharyngeal Composite Score Summary (VPC Sum)(5 years of age)
  • Insufficient Velopharyngeal Function(3 & 5 years of age)
  • Velopharyngeal Insufficiency Symptoms(3 years of age)
  • Canonical Babbling Present(1 year of age)
  • Canonical Babbling Ratio(1 year of age)
  • Canonical Babbling Consonant Inventory(1 year of age)
  • Articulation: Percent Consonant Correct (PCC)(3 and 5 years of age)
  • Articulation: Percent Correct Placement (PCP)(3 and 5 years of age)
  • Articulation: Percent Correct Manner (PCM)(3 and 5 years of age)
  • Articulation: Non-oral Consonant Errors(3 and 5 years of age)
  • Articulation: Oral Consonant Errors(3 and 5 years of age)
  • Postoperative/Long Term Complications: Dehiscence(Up to 30 days postoperatively)
  • Postoperative/Long Term Complications: Infection(Up to 30 days postoperatively)
  • Postoperative/Long Term Complications: Evidence of Fistula(Up to 5 years of age)
  • Hearing Level: Abnormal Transient Otoacoustic Emission (TEOAE)(1 year of age)
  • Hearing Level: Abnormal Soundfield Audiometry(1 year of age)
  • Hearing Level: Abnormal Puretone Audiometry in at Least One Ear.(3 and 5 years of age)
  • Hearing Level: Abnormal Puretone Audiometry in Both Ears(3 and 5 years of age)
  • Hearing Level: Severity of Better Ear(3 and 5 years of age)
  • Middle Ear Function: Flat Line Tympanogram in at Least One Ear(1, 3 and 5 years of age)
  • Middle Ear Function: Flat Line Tympanogram in Both Ears(1, 3 and 5 years of age)

研究者

发起方
Kevin Munro
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kevin Munro

Professor of Audiology

University of Manchester

研究点 (27)

Loading locations...

相似试验